Deepinder Goyal’s Temple wearable shrinks by more than half ahead of pre-orders

Temple’s brain-monitoring wearable is now less than half the size of earlier versions. Pre-orders for a limited launch edition are expected soon, with shipments planned before the end of 2026; pricing has not been disclosed.

— Source published Fri, 21 Aug, 2026, 14:39 IST · First seen Fri, 21 Aug, 2026, 14:47 IST · Source YourStory

What happened

Deepinder Goyal’s brain-monitoring wearable Temple is now less than half its previous size. The company plans to open pre-orders soon for a limited launch

Key facts

  • Device is less than half the size of earlier versions
  • Limited launch edition to ship before end-2026
  • First 100 devices were ready for select founding users
  • $54 million first funding round
  • Approximately $190 million valuation

Why this matters

Temple’s progress makes it a more credible early-stage partner or target in brain-monitoring wearables, with diligence focused on sensor performance, IP, regulatory pathway and scalable manufacturing.

What to watch

  • Pre-order date, price point, refundable-deposit terms, and stated shipment window.
  • Images or specifications showing battery life, sensor count, weight, comfort, and all-day wear design.
  • Whether Temple makes clinical, diagnostic, sleep, focus, stress, meditation, or productivity claims.
  • Evidence of regulatory positioning or disclaimers distinguishing wellness analytics from medical monitoring.
  • Waitlist size, sell-through speed of the limited edition, and any expansion from limited launch to general availability.
  • Reports of manufacturing partners, component sourcing, app subscriptions, or shipment-date revisions.
  • Consumer reaction to data privacy protections and the usefulness of recommendations versus raw brain metrics.
  • Reveal launch-edition pricing, subscription requirements, and regional availability.
  • Publish clearer claims around what the wearable measures, how actionable the insights are, and whether outputs are wellness or medical-grade.
  • Use waitlist access, founder-led demos, and controlled creator partnerships to build scarcity ahead of pre-orders.
  • Secure manufacturing, battery, sensor, and app-support capacity before opening broad orders.
  • Develop privacy messaging for neurological and behavioral data, including storage, sharing, and deletion controls.

Also reported by